 | Drug Safety Update MHRA August PDF.pdf (260KB) | 27/10/2017 | Download |
| | Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia;
risk of hepatitis B reactivation and of opportunistic infections
Corticosteroids: risk of central serous chorioretinopathy with... | |
| Drug Safety Update MHRA July 2017 PDF.pdf (229KB) | 26/07/2017 | Download |
| | Daclizumab (Zinbryta▼) and risk of severe liver injury, Bendamustine (Levact, Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): reports of organ transplant rejection | |
| Drug safety Update June 2017 PDF.pdf (147KB) | 22/06/2017 | Download |
| | Denosumab reports of osteonecrosis of the external auditory canal, brimoniudine gel: risk of cardiovascular effects: not to be applied to damaged skin | |
| Drug Safety Update May 2017 .pdf (200KB) | 26/05/2017 | Download |
| | Finasteride: rare reports of depression and suicidal thoughts | |
| Drug Safety Update April 2017.pdf (132KB) | 28/04/2017 | Download |
| | Valproate and developmental disorders: new alert asking for patient review and further consideration of risk minimisation measures | |
| Drug Safety Update March 2017.pdf (104KB) | 31/03/2017 | Download |
| | | |
| Drug Safety Update February 2017 (86KB) | 21/02/2017 | Download |
| | | |
| Drug Safety Update January 2017.pdf (252KB) | 20/01/2017 | Download |
| | | |
| Drug_Safety_Update October 2016.pdf (77KB) | 19/12/2016 | Download |
| | Etoricoxib (Arcoxia): revised dose recommendation for rheumatoid arthritis and ankylosing spondylitis. Letters sent to healthcare professionals in September 2016, including retigabine withdrawal | |
| Drug Safety Update December 2016.pdf (217KB) | 19/12/2016 | Download |
| | Cobicistat, ritonavir and coadministration with a steroid: risk of systemic corticosteroid adverse effects.
Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially... | |
| Drug Safety Update November_2016.pdf (224KB) | 11/11/2016 | Download |
| | Brimonidine gel (Mirvaso): risk of exacerbation of rosacea.
Show your support for reporting suspected adverse drug reactions.
| |
| Drug Safety Update September 2016 (290KB) | 18/10/2016 | Download |
| | | |
